349 related articles for article (PubMed ID: 25841699)
1. Mitochondrial biology, targets, and drug delivery.
Milane L; Trivedi M; Singh A; Talekar M; Amiji M
J Control Release; 2015 Jun; 207():40-58. PubMed ID: 25841699
[TBL] [Abstract][Full Text] [Related]
2. Targeting drugs to mitochondria.
Heller A; Brockhoff G; Goepferich A
Eur J Pharm Biopharm; 2012 Sep; 82(1):1-18. PubMed ID: 22687572
[TBL] [Abstract][Full Text] [Related]
3. Targeted drug delivery to mammalian mitochondria in living cells.
Weissig V
Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
5. Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria.
Horobin RW; Trapp S; Weissig V
J Control Release; 2007 Aug; 121(3):125-36. PubMed ID: 17658192
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria as therapeutic targets for the treatment of malignant disease.
Fulda S; Kroemer G
Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
8. Insights into cellular uptake of nanoparticles.
Kafshgari MH; Harding FJ; Voelcker NH
Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441
[TBL] [Abstract][Full Text] [Related]
9. [Mitochondrial DDS Opens Innovative Pharmaceutics].
Yamada Y
Yakugaku Zasshi; 2016; 136(1):55-62. PubMed ID: 26725668
[TBL] [Abstract][Full Text] [Related]
10. Delivery of drugs and macromolecules to the mitochondria for cancer therapy.
Lu P; Bruno BJ; Rabenau M; Lim CS
J Control Release; 2016 Oct; 240():38-51. PubMed ID: 26482081
[TBL] [Abstract][Full Text] [Related]
11. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial targeting for development of novel drug strategies in brain injury.
Soustiel JF; Zaaroor M
Cent Nerv Syst Agents Med Chem; 2012 Jun; 12(2):131-45. PubMed ID: 22530837
[TBL] [Abstract][Full Text] [Related]
13. Fusion and fission: interlinked processes critical for mitochondrial health.
Chan DC
Annu Rev Genet; 2012; 46():265-87. PubMed ID: 22934639
[TBL] [Abstract][Full Text] [Related]
14. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
15. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
16. Molecular vehicles for mitochondrial chemical biology and drug delivery.
Rin Jean S; Tulumello DV; Wisnovsky SP; Lei EK; Pereira MP; Kelley SO
ACS Chem Biol; 2014 Feb; 9(2):323-33. PubMed ID: 24410267
[TBL] [Abstract][Full Text] [Related]
17. Role of nanotechnology in developing new therapies for diseases of the nervous system.
Jain KK
Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
[No Abstract] [Full Text] [Related]
18. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine.
Cunha-Oliveira T; Rego AC; Cardoso SM; Borges F; Swerdlow RH; Macedo T; de Oliveira CR
Brain Res; 2006 May; 1089(1):44-54. PubMed ID: 16638611
[TBL] [Abstract][Full Text] [Related]
19. Targeting mitochondrial function for the treatment of breast cancer.
Deus CM; Coelho AR; Serafim TL; Oliveira PJ
Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
[TBL] [Abstract][Full Text] [Related]
20. Strategic disruption of cancer's powerhouse: precise nanomedicine targeting of mitochondrial metabolism.
Lin P; Lu Y; Zheng J; Lin Y; Zhao X; Cui L
J Nanobiotechnology; 2024 Jun; 22(1):318. PubMed ID: 38849914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
